CHIEF FINANCIAL OFFICER · LeonaBio, Inc. · Common Stock
Side
SELL
Value
$4,865
Shares
906
Price
$5.37
Executed
Mar 4, 2026
Disclosed
Mar 5, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 4 executedMar 5, 2026 disclosed
LONA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events+10 / 10
Officer or director change · Other material event filed 15 days after the trade (8-K)
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Renninger Robert filed this Form 4 reporting a open-market sale of LONA on Mar 4, 2026. It became public on Mar 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CHIEF FINANCIAL OFFICER
Renninger Robertcik:0002037968
Issuer
LeonaBio, Inc.cik:0001620463
Revision history · 0
No field has changed since this record was first ingested.
